Kosin Med J.  2013 Jun;28(1):27-33. 10.7180/kmj.2013.28.1.27.

Laparoscopy-assisted Distal Gastrectomy with Systemic D2 Lymphadenectomy for Gastric Cancer: Usefulness of Noncompliance Rate to Validate the Completion of D2

Affiliations
  • 1Department of Surgery, College of Medicine, Kosin University, Busan, Korea. yoonkiyoung@naver.com
  • 2Postgraduate school, College of Medicine, Kosin University, Busan, Korea.

Abstract


OBJECTIVES
Laparoscopy-assisted distal gastrectomy (LADG) is a common surgical procedure that has recently been accepted as safe and feasible for the treatment of early gastric cancer. There have been many efforts to expand the indications of LADG to include the treatment of advanced gastric cancer. The aim of this study was to determine the usefulness of noncompliance rate as an indicator for D2 lymph node dissection (LND) validation in LADG.
METHODS
The subjects were 48 patients who underwent distal gastrectomy with D2 LND at Kosin University Gospel Hospital from October to December 2010. Of them, 28 underwent LADG and 20 underwent open distal gastrectomy (ODG). We compared several factors including noncompliance rate to validate D2 LND.
RESULTS
There were no significant differences in clinicopathologic factors except for BMI and tumor depth between the two groups. The average number of retrieved lymph nodes was significantly greater in the ODG group (45.9 +/- 2.9) than in the LADG group (35.5 +/- 2.0). The noncompliance rate was 43% in the LADG group and 40% in the ODG group with no significant difference.
CONCLUSIONS
In terms of no difference of noncompliance rate, LADG with D2 lymph node dissection is a safe, feasible and oncologicallycamparable with open gastrectomy. A large scaled prospective randomized trial should be needed to confirm the benefit of LADG.

Keyword

Advanced gastric cancer; Gastric neoplasms; Laparoscopy-assisted distal gastrectomy; Noncompliance rate

MeSH Terms

Gastrectomy
Humans
Lymph Node Excision
Lymph Nodes
Stomach Neoplasms

Reference

1.Kitano S., Shiraishi N., Kakisako K., Yasuda K., Inomata M., Adachi Y. Laparoscopy-assisted Billroth-I gastrectomy (LADG) for cancer: our 10 years' experience. Surg Laparosc Endosc Percutan Tech. 2002. 12:204–7.
Article
2.Hur H., Jeon HM., Kim W. Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy for T2b advanced gastric cancers: three years' experience. J Surg Oncol. 2008. 98:515–9.
Article
3.Lee J., Kim W. Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: analysis of consecutive 106 experiences. J Surg Oncol. 2009. 100:693–8.
Article
4.Hwang SI., Kim HO., Yoo CH., Shin JH., Son BH. Laparo-scopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer. Surg Endosc. 2009. 23:1252–8.
Article
5.Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer. 1998. 1:10–24.
6.Hartgrink HH., van de Velde CJ., Putter H., Bonenkamp JJ., Klein Kranenbarg E., Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004. 22:2069–77.
Article
7.Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999. 79:1522–30.
8.Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002. 5:1–5.
Article
9.Huang JL., Wei HB., Zheng ZH., Wei B., Chen TF., Huang Y, et al. Laparoscopy-assisted D2 radical distal gastrectomy for advanced gastric cancer. Dig Surg. 2010. 27:291–6.
Article
10.Tokunaga M., Hiki N., Fukunaga T., Nohara K., Katayama H., Akashi Y, et al. Laparoscopy-assisted distal gastrectomy with D2 lymph node dissection following standardization--a preliminary study. J Gastrointest Surg. 2009. 13:1058–63.
Article
11.Lee JH., Kim YW., Ryu KW., Lee JR., Kim CG., Choi IJ, et al. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients. Ann Surg Oncol. 2007. 14:3148–53.
Article
12.Katai H., Sasako M., Fukuda H., Nakamura K., Hiki N., Saka M, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer. 2010. 13:238–44.
Article
13.COACT. Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer (COACT_1001). 2010. [updated 2010-06-16]; Available from:. http://www.clinicaltrial.gov/ct2/show/NCT01088204?term=COACT&rank=3.
14.KLASS. Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC. 2011. [updated January 25, 2011]; Available from:. http://www.clinicaltrial.gov/ct2/show/NCT01283893?term=KLASS&rank=2.
Full Text Links
  • KMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr